Literature DB >> 21754908

4-(3-Fluoro-4-nitro-phen-yl)morpholin-3-one.

Chang-Jiang Huang, Jiang Wu, Zhi-Qiang Cai, Jing Yuan.   

Abstract

In the title compound, C(10)H(9)FN(2)O(4), the dihedral angle between the benzene ring and the nitro group plane is 11.29 (3)°. The morpholinone ring adopts a twist-chair conformation. In the crystal, mol-ecules are linked by inter-molecular C-H⋯O hydrogen bonds into a chain along the a-axis direction.

Entities:  

Year:  2011        PMID: 21754908      PMCID: PMC3120424          DOI: 10.1107/S1600536811019738

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

The title compound is an inter­mediate in the preparation of derivatives of the factor Xa inhibitor rivaroxaban (systematic name (S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phen­yl]oxazolidin-5-yl]meth­yl}thio­phene-2-carboxamide). For the bioactivity and applications of rivaroxaban, see: Pinto et al. (2010 ▶); Haas (2008 ▶); Squizzato et al. (2009 ▶); Samama & Gerotziafas (2010 ▶); Van Huis et al. (2009 ▶). For the synthesis of other derivatives with morpholone, see: Van Huis et al. (2009 ▶); Zbinden et al. (2009 ▶).

Experimental

Crystal data

C10H9FN2O4 M = 240.19 Triclinic, a = 6.6408 (7) Å b = 7.3788 (10) Å c = 10.8546 (14) Å α = 73.30 (3)° β = 75.39 (3)° γ = 74.30 (3)° V = 481.60 (14) Å3 Z = 2 Mo Kα radiation μ = 0.14 mm−1 T = 113 K 0.22 × 0.20 × 0.10 mm

Data collection

Rigaku Saturn CCD area-detector diffractometer Absorption correction: ψ scan (CrystalClear; Rigaku/MSC, 2009 ▶) T min = 0.970, T max = 0.986 6470 measured reflections 2569 independent reflections 1734 reflections with I > 2σ(I) R int = 0.041

Refinement

R[F 2 > 2σ(F 2)] = 0.039 wR(F 2) = 0.104 S = 0.97 2569 reflections 154 parameters H-atom parameters constrained Δρmax = 0.56 e Å−3 Δρmin = −0.25 e Å−3 Data collection: RAPID-AUTO (Rigaku, 1998 ▶); cell refinement: RAPID-AUTO; data reduction: RAPID-AUTO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: CrystalStructure (Rigaku/MSC, 2009 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811019738/kp2328sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811019738/kp2328Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811019738/kp2328Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H9FN2O4Z = 2
Mr = 240.19F(000) = 248
Triclinic, P1Dx = 1.656 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 6.6408 (7) ÅCell parameters from 1909 reflections
b = 7.3788 (10) Åθ = 2.0–31.1°
c = 10.8546 (14) ŵ = 0.14 mm1
α = 73.30 (3)°T = 113 K
β = 75.39 (3)°Prism, colourless
γ = 74.30 (3)°0.22 × 0.20 × 0.10 mm
V = 481.60 (14) Å3
Rigaku Saturn CCD area-detector diffractometer2569 independent reflections
Radiation source: rotating anode1734 reflections with I > 2σ(I)
multilayerRint = 0.041
Detector resolution: 14.63 pixels mm-1θmax = 29.1°, θmin = 2.0°
ω and φ scansh = −9→9
Absorption correction: ψ scan (CrystalClear; Rigaku/MSC, 2009)k = −10→9
Tmin = 0.970, Tmax = 0.986l = −14→14
6470 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.104H-atom parameters constrained
S = 0.97w = 1/[σ2(Fo2) + (0.0502P)2] where P = (Fo2 + 2Fc2)/3
2569 reflections(Δ/σ)max < 0.001
154 parametersΔρmax = 0.56 e Å3
0 restraintsΔρmin = −0.25 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
F10.38071 (13)0.73231 (13)−0.24062 (8)0.0292 (2)
O10.23003 (15)0.94560 (12)0.40672 (8)0.0192 (2)
O20.04787 (15)0.82852 (15)0.16307 (9)0.0262 (2)
O30.74637 (16)0.59970 (13)−0.37865 (9)0.0241 (2)
O41.03428 (15)0.62270 (13)−0.32888 (9)0.0234 (2)
N10.39251 (16)0.79057 (14)0.18692 (10)0.0139 (2)
N20.84043 (18)0.63168 (15)−0.30564 (10)0.0165 (2)
C10.5325 (2)0.77071 (18)0.27977 (12)0.0161 (3)
H1A0.61520.87390.24560.019*
H1B0.63470.64430.28550.019*
C20.4068 (2)0.78419 (19)0.41571 (12)0.0201 (3)
H2A0.35500.66340.45990.024*
H2B0.50010.79960.46850.024*
C30.0821 (2)0.90024 (19)0.35316 (12)0.0183 (3)
H3A−0.03491.01550.33820.022*
H3B0.01960.79560.41830.022*
C40.1736 (2)0.83638 (18)0.22515 (12)0.0164 (3)
C50.4968 (2)0.75696 (16)0.06139 (12)0.0132 (3)
C60.7205 (2)0.71941 (17)0.03016 (12)0.0160 (3)
H60.79880.71920.09240.019*
C70.8283 (2)0.68282 (17)−0.09000 (12)0.0161 (3)
H70.97950.6591−0.10950.019*
C80.7182 (2)0.68025 (17)−0.18264 (12)0.0143 (3)
C90.4967 (2)0.72366 (18)−0.15317 (12)0.0158 (3)
C100.3858 (2)0.76283 (17)−0.03458 (12)0.0160 (3)
H100.23450.7938−0.01780.019*
U11U22U33U12U13U23
F10.0201 (5)0.0495 (5)0.0226 (4)−0.0038 (4)−0.0079 (4)−0.0158 (4)
O10.0176 (5)0.0226 (5)0.0198 (5)−0.0014 (4)−0.0046 (4)−0.0102 (4)
O20.0134 (5)0.0476 (6)0.0235 (5)−0.0093 (5)−0.0009 (4)−0.0173 (5)
O30.0289 (6)0.0285 (5)0.0192 (5)−0.0068 (4)−0.0067 (4)−0.0099 (4)
O40.0162 (5)0.0297 (5)0.0214 (5)−0.0027 (4)0.0012 (4)−0.0078 (4)
N10.0125 (5)0.0173 (5)0.0125 (5)−0.0031 (4)−0.0020 (4)−0.0049 (4)
N20.0192 (6)0.0143 (5)0.0148 (5)−0.0029 (5)−0.0020 (5)−0.0028 (4)
C10.0135 (6)0.0200 (7)0.0159 (6)−0.0013 (5)−0.0055 (5)−0.0056 (5)
C20.0196 (7)0.0234 (7)0.0158 (6)0.0000 (6)−0.0051 (5)−0.0053 (5)
C30.0162 (7)0.0218 (7)0.0173 (6)−0.0031 (5)−0.0026 (5)−0.0063 (5)
C40.0147 (7)0.0177 (7)0.0163 (6)−0.0045 (5)−0.0007 (5)−0.0044 (5)
C50.0153 (6)0.0117 (6)0.0129 (6)−0.0041 (5)−0.0021 (5)−0.0029 (5)
C60.0154 (7)0.0182 (7)0.0162 (6)−0.0045 (5)−0.0048 (5)−0.0043 (5)
C70.0133 (6)0.0181 (7)0.0175 (6)−0.0041 (5)−0.0027 (5)−0.0047 (5)
C80.0161 (7)0.0134 (6)0.0132 (6)−0.0033 (5)−0.0014 (5)−0.0036 (5)
C90.0166 (7)0.0180 (7)0.0153 (6)−0.0042 (5)−0.0071 (5)−0.0036 (5)
C100.0111 (6)0.0188 (7)0.0183 (6)−0.0018 (5)−0.0035 (5)−0.0051 (5)
F1—C91.3438 (13)C2—H2B0.9900
O1—C31.4118 (14)C3—C41.5223 (18)
O1—C21.4286 (16)C3—H3A0.9900
O2—C41.2193 (14)C3—H3B0.9900
O3—N21.2292 (13)C5—C101.4050 (16)
O4—N21.2349 (13)C5—C61.4061 (18)
N1—C41.3823 (16)C6—C71.3831 (17)
N1—C51.4223 (16)C6—H60.9500
N1—C11.4885 (15)C7—C81.3910 (16)
N2—C81.4630 (16)C7—H70.9500
C1—C21.5171 (18)C8—C91.3912 (18)
C1—H1A0.9900C9—C101.3795 (18)
C1—H1B0.9900C10—H100.9500
C2—H2A0.9900
C3—O1—C2107.55 (9)C4—C3—H3B108.5
C4—N1—C5123.48 (11)H3A—C3—H3B107.5
C4—N1—C1120.11 (10)O2—C4—N1124.24 (12)
C5—N1—C1116.39 (10)O2—C4—C3117.50 (12)
O3—N2—O4123.82 (11)N1—C4—C3118.25 (11)
O3—N2—C8118.74 (11)C10—C5—C6118.08 (11)
O4—N2—C8117.43 (10)C10—C5—N1122.88 (11)
N1—C1—C2112.26 (10)C6—C5—N1119.03 (11)
N1—C1—H1A109.2C7—C6—C5120.88 (12)
C2—C1—H1A109.2C7—C6—H6119.6
N1—C1—H1B109.2C5—C6—H6119.6
C2—C1—H1B109.2C6—C7—C8120.88 (12)
H1A—C1—H1B107.9C6—C7—H7119.6
O1—C2—C1109.95 (10)C8—C7—H7119.6
O1—C2—H2A109.7C7—C8—C9118.10 (12)
C1—C2—H2A109.7C7—C8—N2118.60 (11)
O1—C2—H2B109.7C9—C8—N2123.31 (11)
C1—C2—H2B109.7F1—C9—C10116.88 (12)
H2A—C2—H2B108.2F1—C9—C8121.12 (12)
O1—C3—C4114.95 (11)C10—C9—C8121.99 (12)
O1—C3—H3A108.5C9—C10—C5119.97 (12)
C4—C3—H3A108.5C9—C10—H10120.0
O1—C3—H3B108.5C5—C10—H10120.0
C4—N1—C1—C26.24 (15)N1—C5—C6—C7178.93 (10)
C5—N1—C1—C2−172.77 (10)C5—C6—C7—C8−0.66 (19)
C3—O1—C2—C170.39 (13)C6—C7—C8—C92.70 (19)
N1—C1—C2—O1−46.84 (14)C6—C7—C8—N2−177.12 (11)
C2—O1—C3—C4−52.83 (13)O3—N2—C8—C7168.82 (11)
C5—N1—C4—O29.8 (2)O4—N2—C8—C7−10.19 (16)
C1—N1—C4—O2−169.11 (11)O3—N2—C8—C9−10.99 (18)
C5—N1—C4—C3−170.40 (11)O4—N2—C8—C9170.00 (11)
C1—N1—C4—C310.66 (17)C7—C8—C9—F1176.97 (10)
O1—C3—C4—O2−167.37 (11)N2—C8—C9—F1−3.22 (19)
O1—C3—C4—N112.84 (16)C7—C8—C9—C10−1.95 (19)
C4—N1—C5—C10−1.57 (18)N2—C8—C9—C10177.87 (11)
C1—N1—C5—C10177.41 (11)F1—C9—C10—C5−179.83 (10)
C4—N1—C5—C6177.30 (11)C8—C9—C10—C5−0.87 (19)
C1—N1—C5—C6−3.73 (16)C6—C5—C10—C92.90 (18)
C10—C5—C6—C7−2.16 (18)N1—C5—C10—C9−178.23 (11)
D—H···AD—HH···AD···AD—H···A
C6—H6···O2i0.952.393.2635 (16)153
C2—H2B···O3ii0.992.503.3244 (19)140
C1—H1B···O4iii0.992.573.515 (2)161
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C6—H6⋯O2i0.952.393.2635 (16)153
C2—H2B⋯O3ii0.992.503.3244 (19)140
C1—H1B⋯O4iii0.992.573.515 (2)161

Symmetry codes: (i) ; (ii) ; (iii) .

  7 in total

Review 1.  Factor Xa inhibitors: next-generation antithrombotic agents.

Authors:  Donald J P Pinto; Joanne M Smallheer; Daniel L Cheney; Robert M Knabb; Ruth R Wexler
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit.

Authors:  Katrin Groebke Zbinden; Lilli Anselm; David W Banner; Jörg Benz; Francesca Blasco; Guillaume Décoret; Jacques Himber; Bernd Kuhn; Narendra Panday; Fabienne Ricklin; Philippe Risch; Daniel Schlatter; Martin Stahl; Stefan Thomi; Robert Unger; Wolfgang Haap
Journal:  Eur J Med Chem       Date:  2009-01-03       Impact factor: 6.514

4.  New direct thrombin inhibitors.

Authors:  Alessandro Squizzato; Francesco Dentali; Luigi Steidl; Walter Ageno
Journal:  Intern Emerg Med       Date:  2009-09-15       Impact factor: 3.397

5.  Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action.

Authors:  Chad A Van Huis; Agustin Casimiro-Garcia; Christopher F Bigge; Wayne L Cody; Danette A Dudley; Kevin J Filipski; Ronald J Heemstra; Jeffrey T Kohrt; Robert J Leadley; Lakshmi S Narasimhan; Thomas McClanahan; Igor Mochalkin; Michael Pamment; J Thomas Peterson; Vaishali Sahasrabudhe; Robert P Schaum; Jeremy J Edmunds
Journal:  Bioorg Med Chem       Date:  2009-02-03       Impact factor: 3.641

Review 6.  Newer anticoagulants in 2009.

Authors:  Meyer Michel Samama; Grigoris T Gerotziafas
Journal:  J Thromb Thrombolysis       Date:  2010-01       Impact factor: 2.300

Review 7.  New oral Xa and IIa inhibitors: updates on clinical trial results.

Authors:  Sylvia Haas
Journal:  J Thromb Thrombolysis       Date:  2007-10-27       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.